156 related articles for article (PubMed ID: 12393509)
1. Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines.
Ge Y; Jensen TL; Matherly LH; Taub JW
Blood; 2003 Feb; 101(4):1551-7. PubMed ID: 12393509
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of cell-specific expression of the human cystathionine beta -synthase gene by differential binding of Sp1/Sp3 to the -1b promoter.
Ge Y; Matherly LH; Taub JW
J Biol Chem; 2001 Nov; 276(47):43570-9. PubMed ID: 11562358
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.
Ge Y; Konrad MA; Matherly LH; Taub JW
Biochem J; 2001 Jul; 357(Pt 1):97-105. PubMed ID: 11415440
[TBL] [Abstract][Full Text] [Related]
4. The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines.
Ge Y; Jensen TL; Stout ML; Flatley RM; Grohar PJ; Ravindranath Y; Matherly LH; Taub JW
Cancer Res; 2004 Jan; 64(2):728-35. PubMed ID: 14744791
[TBL] [Abstract][Full Text] [Related]
5. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
6. Synergistic regulation of human cystathionine-beta-synthase-1b promoter by transcription factors NF-YA isoforms and Sp1.
Ge Y; Jensen TL; Matherly LH; Taub JW
Biochim Biophys Acta; 2002 Dec; 1579(2-3):73-80. PubMed ID: 12427542
[TBL] [Abstract][Full Text] [Related]
7. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
Ge Y; Dombkowski AA; LaFiura KM; Tatman D; Yedidi RS; Stout ML; Buck SA; Massey G; Becton DL; Weinstein HJ; Ravindranath Y; Matherly LH; Taub JW
Blood; 2006 Feb; 107(4):1570-81. PubMed ID: 16249385
[TBL] [Abstract][Full Text] [Related]
9. The dominant role of Sp1 in regulating the cystathionine beta-synthase -1a and -1b promoters facilitates potential tissue-specific regulation by Kruppel-like factors.
Maclean KN; Kraus E; Kraus JP
J Biol Chem; 2004 Mar; 279(10):8558-66. PubMed ID: 14670973
[TBL] [Abstract][Full Text] [Related]
10. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
[TBL] [Abstract][Full Text] [Related]
11. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
Taub JW; Huang X; Matherly LH; Stout ML; Buck SA; Massey GV; Becton DL; Chang MN; Weinstein HJ; Ravindranath Y
Blood; 1999 Aug; 94(4):1393-400. PubMed ID: 10438727
[TBL] [Abstract][Full Text] [Related]
12. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
[TBL] [Abstract][Full Text] [Related]
13. Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity.
Ge Y; Jensen TL; Matherly LH; Taub JW
J Biol Chem; 2003 Dec; 278(50):49901-10. PubMed ID: 14514691
[TBL] [Abstract][Full Text] [Related]
14. Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions.
Yamada K; Tanaka T; Miyamoto K; Noguchi T
J Biol Chem; 2000 Jun; 275(24):18129-37. PubMed ID: 10748033
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.
Jean D; Guillaume N; Frade R
Biochem J; 2002 Jan; 361(Pt 1):173-84. PubMed ID: 11742542
[TBL] [Abstract][Full Text] [Related]
16. Involvement of specific proteins (Sp1/Sp3) and nuclear factor Y in basal transcription of the distal promoter of the rat pyruvate carboxylase gene in beta-cells.
Sunyakumthorn P; Boonsaen T; Boonsaeng V; Wallace JC; Jitrapakdee S
Biochem Biophys Res Commun; 2005 Apr; 329(1):188-96. PubMed ID: 15721292
[TBL] [Abstract][Full Text] [Related]
17. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
Rothem L; Aronheim A; Assaraf YG
J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
[TBL] [Abstract][Full Text] [Related]
20. Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO.
Xu Y; Carr LG
Gene; 2001 Aug; 274(1-2):119-28. PubMed ID: 11675004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
